Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin
- PMID: 19568285
- DOI: 10.1038/nrd2358-c1
Novel therapeutic strategies for multiple sclerosis: potential of intravenous immunoglobulin
Comment on
-
Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.Nat Rev Drug Discov. 2008 Nov;7(11):909-25. doi: 10.1038/nrd2358. Nat Rev Drug Discov. 2008. PMID: 18974749 Review.
Similar articles
-
Intravenous immunoglobulin and multiple sclerosis.Clin Rev Allergy Immunol. 2005 Dec;29(3):247-54. doi: 10.1385/CRIAI:29:3:247. Clin Rev Allergy Immunol. 2005. PMID: 16391400 Review.
-
[Immunoglobulin G is effective in multiple sclerosis].Ugeskr Laeger. 2005 Jan 3;167(1):81; author reply 81. Ugeskr Laeger. 2005. PMID: 15675176 Danish. No abstract available.
-
Bullous pemphigoid in a patient with multiple sclerosis being treated with human immunoglobulin.J Eur Acad Dermatol Venereol. 2015 Apr;29(4):821-2. doi: 10.1111/jdv.12425. Epub 2014 Mar 4. J Eur Acad Dermatol Venereol. 2015. PMID: 24588974 No abstract available.
-
Intravenous immunoglobulins in MS: a panacea lacking approval?Int MS J. 2005 Apr;12(1):1-2. Int MS J. 2005. PMID: 15955271 No abstract available.
-
Potential role of immunoglobulin replacement therapy on MRI measures in multiple sclerosis: a systematic review.Expert Rev Clin Immunol. 2015;11(12):1291-5. doi: 10.1586/1744666X.2015.1102059. Epub 2015 Oct 21. Expert Rev Clin Immunol. 2015. PMID: 26488634 Review.
Cited by
-
Role of pathogens in multiple sclerosis.Int Rev Immunol. 2014 Jul-Aug;33(4):266-83. doi: 10.3109/08830185.2013.823422. Epub 2013 Nov 22. Int Rev Immunol. 2014. PMID: 24266364 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical